Who owns BioMarin Pharmaceutical?

Key details on BioMarin Pharmaceutical (Ticker: BMRN)

Who owns BioMarin Pharmaceutical?

Is BMRN a good stock to own? Find out who bought BioMarin Pharmaceutical, who sold BioMarin Pharmaceutical (BMRN) stock, and who holds a large position in BioMarin Pharmaceutical.

Fund Name Number of Shares Share Valuation As Of
Capital Research Global Investors^ 17.42M $1.22B Dec. 31, 2013
Sands Capital Management 10.24M $720.12M Dec. 31, 2013
Jennison Associates 9.40M $660.26M Dec. 31, 2013
FMR 7.79M $547.72M Dec. 31, 2013
Vanguard 7.61M $535.08M Dec. 31, 2013
PRIMECAP Management Company 7.56M $531.86M Dec. 31, 2013
Wells Fargo & Company 3.86M $271.68M Dec. 31, 2013
Capital World Investors^ 3.68M $205.21M June 30, 2013
BlackRock Institutional Trust Company, N.A. 3.36M $236.65M Dec. 31, 2013
Inves 3.19M $128.31M Sept. 30, 2012
STATE STREET CORPORATION 3.19M $223.82M Dec. 31, 2013
Manning & Napier Advisors 3.04M $96.76M Sept. 30, 2011
Cramer Rosenthal McGlynn 2.82M $96.96M Dec. 31, 2011
T. Rowe Price Associates 2.68M $188.11M Dec. 31, 2013
BlackRock Fund Advisors 2.66M $187.18M Dec. 31, 2013
William Blair $ Company 2.64M $185.46M Dec. 31, 2013
Altrinsic Global Advisors 2.55M $158.71M March 31, 2013
S.A.C. Capital Advisors 2.43M $119.44M Dec. 31, 2012
TCW 2.41M $169.44M Dec. 31, 2013
Columbia Wanger Asset Management 2.36M $170.46M Sept. 30, 2013
Porter Orlin 2.31M $128.67M June 30, 2013

Who sold BioMarin Pharmaceutical?

Fund Name Date Sold Number of Shares Sold Share Valuation
Sectoral Asset Management Sept. 30, 2011 3.54M $112.96M
Munder Capital Management Sept. 30, 2011 2.98M $94.96M
OrbiMed Advisors June 30, 2011 2.64M $71.86M
Ridgeback Capital Investments March 31, 2011 2.40M $60.31M